1S70 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cartesian Therapeutics Inc

Watchlist Manager

Watchlist

Price: 8.9 EUR -1.66% Market Closed

Market Cap: €231.4m

	Cartesian Therapeutics Inc F:1S70	US
P	Pearson PLC DUS:PES	UK
N	Novartis AG SWB:NOT	CH
E	Eagle Bancorp Montana Inc F:8F5	US

Profitability Summary

Cartesian Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-8 339%

Negative 3Y Average Operating Margin

-1 856%

Declining Operating Margin

-97% > -8 339%

Negative Net Margin

-8 699%

Negative 3Y Average Net Margin

-1 779%

Declining Net Margin

-72% > -8 699%

Negative Free Cash Flow Margin

-4 359%

Negative 3Y Average Free Cash Flow Margin

-1 182%

Declining Free Cash Flow Margin

-55% > -4 359%

Exceptional ROE

182%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-64%

ROIC is Increasing

-130% > -75%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.